Easton Net Current Asset Value from 2010 to 2026
| EAPH Stock | USD 0.00001 0.00 0.00% |
Net Current Asset Value | First Reported 2010-12-31 | Previous Quarter (362.88) | Current Value (381.02) | Quarterly Volatility 10.8621047 |
Check Easton Pharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Easton Pharmaceutica's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 161.2 K or Research Development of 179.8 K, as well as many indicators such as Price To Sales Ratio of 0.94, Dividend Yield of 0.0 or PTB Ratio of 0.11. Easton financial statements analysis is a perfect complement when working with Easton Pharmaceutica Valuation or Volatility modules.
Easton | Net Current Asset Value | Build AI portfolio with Easton Stock |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Easton Pharmaceutica Correlation against competitors. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is there potential for Pharmaceuticals market expansion? Will Easton introduce new products? Factors like these will boost the valuation of Easton Pharmaceutica. Projected growth potential of Easton fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Easton Pharmaceutica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Easton Pharmaceutica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Easton Pharmaceutica's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.